Clorox Reports 18 Percent EPS Growth in Q2; Raises Fiscal Year 2016 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Clorox (CLX) Proves Conservative on Initial FY16 Guidance - UBS Raises PT to $110
February 5, 2016 9:49 AM ESTUBS reiterated a Sell rating on Clorox (NYSE: CLX), and raised the price target to $110.00 (from $105.00), following the company's 2Q earnings report. CLX reported $1.14 in EPS, beating consensus estimates of $1.05. This outperformance was driven largely by +210 bps in GM expansion. CLX did not raise FY16... More
Clorox (CLX) Tops Q2 EPS by 9c; Boosts Outlook Modestly
February 4, 2016 6:33 AM ESTClorox (NYSE: CLX) reported Q2 EPS of $1.14, $0.09 better than the analyst estimate of $1.05. Revenue for the quarter came in at $1.35 billion versus the consensus estimate of $1.35 billion.
GUIDANCE:
Clorox sees FY2016 EPS of $4.75-$4.90, versus prior guidance of $4.68-$4.83 and the... More
